[HTML][HTML] Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia
H Inaba, E Coustan-Smith, X Cao… - Journal of Clinical …, 2012 - ncbi.nlm.nih.gov
Journal of Clinical Oncology, 2012•ncbi.nlm.nih.gov
Purpose In acute myeloid leukemia (AML), initial treatment response by morphologic
analysis of bone marrow predicts long-term outcome. Response can now be assessed by
minimal residual disease (MRD) monitoring with flow cytometry or polymerase chain
reaction (PCR). We determined the relation among the results of these approaches and their
prognostic value.
analysis of bone marrow predicts long-term outcome. Response can now be assessed by
minimal residual disease (MRD) monitoring with flow cytometry or polymerase chain
reaction (PCR). We determined the relation among the results of these approaches and their
prognostic value.
Abstract
Purpose
In acute myeloid leukemia (AML), initial treatment response by morphologic analysis of bone marrow predicts long-term outcome. Response can now be assessed by minimal residual disease (MRD) monitoring with flow cytometry or polymerase chain reaction (PCR). We determined the relation among the results of these approaches and their prognostic value.
ncbi.nlm.nih.gov